Aude Espinasse

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Joaquı́n Mateo, Núria Porta, Diletta Bianchini et al. · The Lancet Oncology · 2019 · 632 citations · Full text

A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults

Sharon Simpson, Rachel McNamara, Christine Shaw et al. · Health Technology Assessment · 2015 · 51 citations · Full text

TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations.

Joaquı́n Mateo, Núria Porta, Ursula McGovern et al. · Journal of Clinical Oncology · 2019 · 45 citations

Urology, Phase Ii, Genitourinary Cancer +15

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

Christina Yap, Olga Solovyeva, Johann S. de Bono et al. · BMJ · 2023 · 43 citations · Full text

Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residents

David Gillespie, Kerenza Hood, Antony Bayer et al. · Age and Ageing · 2015 · 37 citations · Full text